Cardiac Surgery Risk Scores: EuroSCORE and STS Explained

When a heart surgeon tells you an operation is "high risk" or "low risk," that is not an impression or a feeling. It is a number, produced by validated tools called cardiac surgery risk scores EuroSCORE and the STS score being the two most widely used in the world. These calculators take details of your health — your age, your kidney function, your lung disease, the type of operation you need — and turn them into an estimate of what could go wrong. If you or a family member is facing valve surgery, coronary bypass, or another cardiac procedure, understanding these numbers will change the way you hear every conversation that follows. This guide explains what the scores measure, how they differ, where they fall short, and how to use them to make a decision you genuinely trust.

What Are Cardiac Surgery Risk Scores?

Risk stratification is the practice of sorting patients into groups by how likely complications are, before anything happens. In cardiac surgery it exists because outcomes vary enormously: a fit 55-year-old having an uncomplicated bypass faces very different odds from an 84-year-old with kidney failure and previous strokes having the same operation. Treating those two patients as if they were the same would be careless medicine.

Why scores were developed. In the 1990s, surgical teams in Europe and North America began collecting data on thousands of operations to find out which factors actually predicted death and serious complications. The European System for Cardiac Operative Risk Evaluation — EuroSCORE — was published in 1999 from nearly 20,000 patients across Europe, and the Society of Thoracic Surgeons (STS) in the United States built its own models from an even larger national database. Both are updated periodically as surgery and patient populations change.

What the numbers actually mean. A score is expressed as a percentage — for example, a 4% predicted risk of in-hospital mortality. It is an average, not a prophecy for you as an individual. Two patients with identical scores can have very different outcomes, because no calculator captures every variable. Surgeons use the score as a starting point for the conversation, then adjust it with clinical judgement, frailty assessment, and imaging.

In our practice, every case is reviewed by the multidisciplinary team against international practice guidelines before a recommendation is given, and the risk estimate is always explained in plain words alongside the alternatives. The patient receives a clear proposal, and the final decision is always theirs.

How Does the EuroSCORE Calculation Work?

The EuroSCORE calculation explained simply: it starts with a set of patient factors, assigns each one a weight, and adds them together to produce a predicted risk. The original model used three groups of variables.

• Patient-related factors: age (increasing weight above 60), sex, chronic lung disease, diabetes on insulin, previous heart attack, poor mobility, and kidney function.
• Cardiac-related factors: poor heart pumping function (low ejection fraction), recent heart attack within 90 days, unstable angina, pulmonary hypertension, and urgent or emergency status of the operation.
• Operation-related factors: the type of surgery (valve, bypass, combined procedures), surgery on the thoracic aorta, previous cardiac surgery, and whether the operation is done urgently.

Weighting the factors. Each factor carries a point value based on how strongly it predicted poor outcomes in the original database. Emergency status and reoperative surgery carry heavy weights because they were the strongest predictors. The total is then converted into a percentage estimate of in-hospital death.

What the score does not include. The EuroSCORE was built before several variables now known to matter — frailty, cognitive impairment, frailty-related functional decline, and detailed measures of liver function — were routinely captured. This matters especially for older patients, which is a limitation we return to below.

What Is the Difference Between Additive and Logistic EuroSCORE?

Two versions of the original score circulated, and knowing which one your report refers to matters, because the numbers are not interchangeable.

Additive EuroSCORE points. The additive version simply sums the points assigned to each risk factor. It is easy to calculate by hand at the bedside, which is why it spread quickly. Its weakness is mathematical: it treats every risk factor as equally additive, so patients with many factors come out with risk estimates that are too low.

Logistic EuroSCORE meaning. The logistic version applies the same factors through a statistical (logistic regression) formula that accounts for the way risks compound. A patient with an additive score of 9 points might have a logistic risk of 12–15%, because the combination of factors multiplies rather than adds danger. For high-risk patients, the logistic score is meaningfully more accurate, and it became the standard number quoted in heart team discussions.

Why this confusion persists. Some older reports and papers quote the additive score, others the logistic score, without always saying which. If you are shown a EuroSCORE number, it is entirely reasonable to ask which version was used and what the other would be.

What Is the EuroSCORE II Calculator and Why Was It Created?

By around 2010 it had become clear that the original EuroSCORE was systematically overestimating risk. Surgical results had improved — better techniques, better perfusion, better postoperative care — but the score still reflected outcomes from the 1990s. An overestimated risk has real consequences: patients can be turned down for surgery they would have survived, or pushed toward less invasive options for the wrong reason.

The recalibration. EuroSCORE II was published in 2012, built from more than 22,000 patients across nearly 180 centres. It introduced several new variables — poor mobility as a marker of frailty, insulin-dependent diabetes, and functional capacity measured in NYHA class — and recalibrated every weight to contemporary outcomes.

What changed in practice. For an identical patient, the EuroSCORE II calculator typically returns a lower number than the old logistic EuroSCORE. That is not because surgery became safer by magic; it is because the reference population now reflects real modern performance. Studies comparing the two have shown EuroSCORE II predicts outcomes more accurately, particularly in the middle and upper risk ranges.

Where it is used today. EuroSCORE II is the standard in most of Europe, Latin America, and much of Asia. If your team quotes a single "EuroSCORE" today, it is almost always EuroSCORE II — but confirming this is worth one question.

What Is the STS Score and How Does It Differ From EuroSCORE?

The STS score comes from the Society of Thoracic Surgeons national database in the United States, which collects detailed information on hundreds of thousands of operations. Unlike EuroSCORE, which produces one overall mortality estimate, the STS models are operation-specific and predict several outcomes at once.

Operation-specific models. There are separate STS calculators for isolated coronary bypass, isolated aortic or mitral valve surgery, combined procedures, and other operations. Each model was built from patients who actually had that operation, which makes its estimates sharper for that procedure than a general model can be.

Multiple outcomes predicted. The STS output includes predicted risk of operative mortality, but also stroke, renal failure, prolonged ventilation, reoperation, deep sternal wound infection, and prolonged hospital stay. For a patient who cares less about the headline number and more about "will I end up on a ventilator for a week?", this granularity is genuinely useful.

The low-risk range problem. Neither score discriminates well among patients at the very low end of risk — when almost everyone does well, the calculators cannot tell the 0.8% patient from the 1.5% patient. This is a property of statistics, not a flaw in either tool, and it is why low-risk estimates should never be quoted with false precision.

Research such as the Journal of the American Heart Association analysis of next-day discharge and readmission after uncomplicated self-expanding transcatheter aortic valve replacement shows how outcomes in contemporary low-risk cohorts can be captured and studied with far more granularity than the older risk models ever attempted.

EuroSCORE vs STS Score: Which One Should You Trust?

This is one of the questions we hear most often, and the honest answer is: both, with clear eyes about what each is good at.

Which population was studied? The STS models reflect North American practice and patient demographics; EuroSCORE reflects European practice. If your surgery is happening in Latin America or Europe, the EuroSCORE II population is arguably closer to the team and system that will treat you. If you are comparing against published US outcomes, the STS number travels better.

Which procedure is planned? For isolated coronary bypass, the STS model is the more operation-specific of the two. For combined or less common procedures, the difference narrows and neither model is clearly superior.

How much do they disagree? For the same patient, the two scores often differ by a few percentage points, and occasionally by more. Discordant scores are not a red flag; they are a prompt for the heart team to look at the patient directly and consider what each calculator is missing — usually frailty, functional status, or anatomy.

A short comparison.

• Origin: EuroSCORE — European database; STS — United States national database.
• Output: EuroSCORE II — one overall mortality estimate; STS — mortality plus several complication risks, per procedure.
• Best use: run both when possible; agreement builds confidence, disagreement prompts closer review.

How Do Risk Scores Guide TAVR and Minimally Invasive Candidacy?

Nowhere do these numbers matter more than in deciding who is a candidate for TAVR — transcatheter aortic valve replacement — the procedure that replaces the aortic valve through a catheter, usually from the groin, without opening the chest.

Historical use of the scores. Early TAVR trials selected patients using the logistic EuroSCORE or STS score to define "high" and "prohibitive" risk. Patients above roughly the 8% range on either score were considered too high risk for conventional open surgery and became candidates for the transcatheter route. As TAVR proved itself, trials expanded into intermediate-risk and then low-risk populations, with low-risk TAVR trials being among the pivotal studies that supported offering TAVR to carefully selected low-risk patients.

Why the scores alone are no longer enough. What these trials revealed is that risk scores predict mortality reasonably but predict *recovery quality* poorly. A patient with a modest EuroSCORE II can still be a poor TAVR candidate because of frailty, porcelain aorta, or unfavourable access vessels. Conversely, some "high score" patients are physiologically robust and do well with either approach. This is why modern guidelines ask teams to combine the score with frailty assessment, imaging of the access route, and a heart team discussion.

What the decision looks like now. The choice between surgical valve replacement and TAVR is no longer "score above a line, get the catheter." It is a structured comparison of age, valve anatomy, life expectancy, need for other concurrent procedures, and patient preference.

Studies of delirium after major operations, including the analysis in PLOS ONE of risk factors for postoperative delirium in elderly patients, reinforce why risk assessment must look beyond mortality to the complications that shape recovery for older patients specifically.

What Risk Factors Do Heart Surgery Risk Stratification Tools Include?

When a team runs heart surgery risk stratification, the calculator asks for a specific list of inputs. Knowing them in advance means you arrive at your consultation with the right information ready.

The big five. Age, urgency of the operation, whether this is a reoperation (previous heart surgery), kidney function (creatinine level or dialysis dependence), and heart pumping function (ejection fraction) carry the heaviest weights in both EuroSCORE II and the STS models. Emergency surgery roughly multiplies risk, and kidney failure does the same.

The supporting list. Chronic lung disease, diabetes (especially insulin-treated), peripheral artery disease, previous stroke, recent heart attack, unstable angina, pulmonary hypertension, poor mobility, and sex all contribute. Female sex carries a small additional weight in several models, reflecting historically worse outcomes that partly reflect referral and anatomy differences.

What is notably absent. Neither mainstream score directly incorporates frailty in the way modern geriatric assessment would, detailed nutrition status, or psychosocial support. A meticulous 82-year-old who walks three miles a day can carry the same score as a frail 82-year-old who cannot leave a chair — and their recoveries will not look alike. This is exactly why the score is the beginning of assessment, not the end of it.

Are Risk Scores Accurate for Older and Frailer Patients?

This is where honest teams acknowledge the limits of the tools, and it matters most for the patients asking the questions.

Overestimation in the modern era. Several studies have found that both scores tend to overestimate mortality in contemporary cohorts — actual deaths are often lower than predicted, especially in high-score patients. One interpretation is encouraging: surgical and transcatheter care has genuinely improved. The practical caution is that decisions made on an inflated number can deny someone a procedure they would have done well with.

The frailty gap. Poor mobility entered EuroSCORE II as a proxy for frailty, but a single mobility question is a blunt instrument. Comprehensive geriatric assessment — grip strength, walking speed, cognition, nutrition — identifies vulnerable patients whom the scores classify as moderate risk. Delirium risk, prolonged rehabilitation need, and loss of independence are poorly captured by any percentage.

Extremes of the range. Very high scores (above roughly 20–30%) and very low scores are both poorly calibrated. At the top end, the models run out of comparable patients in their databases. At the bottom end, as noted, everything looks safe and the differences are noise.

How to Use Your Risk Score to Ask Better Questions

A risk score in your hands is leverage. It lets you move from "the doctor says I'm high risk" to a specific, answerable conversation.

Ask which score and which version. Was it EuroSCORE II or the old logistic EuroSCORE? Was the STS model run for your specific procedure? You are entitled to see the number and know what went into it.

Ask what the score is being used to justify. Is it steering you toward TAVR, toward open surgery, or toward declining surgery altogether? If a high number is closing a door, ask whether frailty assessment, a second operation reading, or an alternative access route changes the picture.

Ask about complications, not just mortality. The STS output predicts stroke, kidney injury, and prolonged ventilation — outcomes that matter enormously to daily life. Ask your team what your profile suggests for each.

Ask for a second opinion with the same data. Bring your echocardiogram, catheterisation films, and blood work. Five reasons to ask for a second opinion before high-risk surgery include confirmation of the indication, validation of the risk estimate, a check on procedural choice, access to a different surgical approach, and simple peace of mind. We encourage second opinions and treat seeking one as a normal part of deciding about heart surgery, not as a betrayal of the first team.

The right questions to bring:

• Version check: "Which calculator and version produced this number, and what are the inputs?"
• Direction check: "Is this score driving the choice of procedure, and what would change it?"
• Whole-person check: "What does my frailty, mobility, and recovery capacity suggest that the score does not capture?"

Choosing Your Team: What the Score Cannot Tell You

A final word on the piece of the puzzle no calculator can model: the team performing the operation and the system around it.

Volume, experience, and outcomes. Outcomes vary meaningfully between centres and between surgeons, and risk models do not capture this. A team that performs a procedure regularly, tracks its own results, and can discuss them honestly is worth a great deal of the percentage point you were given.

Transparency as a signal. A good team will show you the score, explain its limitations, and invite your questions without defensiveness. Teams that bristle at "what is my EuroSCORE?" are telling you something about how the rest of your care will go.

How to begin with us. The first contact is a free video consultation: we get to know the patient, talk through the condition, and say which studies are still needed so no unnecessary ones are ordered. A face-to-face visit at the consulting rooms follows when the patient decides to go ahead. We have consulting rooms in Guadalajara, Querétaro and Hermosillo.

Summary. Cardiac surgery risk scores EuroSCORE and the STS score are tools for starting a conversation, not ending one. EuroSCORE II gives a single, contemporary estimate of operative mortality; the STS models predict mortality plus a range of complications, per procedure. Both are imperfect in the extremes, both underweight frailty, and both should be read alongside a direct assessment of you as a person. If you or a family member has been given a risk score and you do not fully understand what it means or what it is being used to justify, that uncertainty deserves a proper conversation — book a consultation with a qualified cardiac team and bring every question you have. The final decision is always yours, and you deserve the information to make it well.